Moderna (MRNA) News Today $33.30 -0.43 (-1.27%) As of 11:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Meitav Investment House Ltd. Sells 184,043 Shares of Moderna, Inc. (NASDAQ:MRNA)Meitav Investment House Ltd. decreased its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 81.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,860 shares of the company'February 21 at 6:09 AM | marketbeat.comRhumbline Advisers Sells 20,902 Shares of Moderna, Inc. (NASDAQ:MRNA)Rhumbline Advisers cut its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 3.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 525,003 shares of the company's stock after sFebruary 21 at 3:32 AM | marketbeat.comMultiple states pushing to ban or restrict mRNA vaccinesFebruary 20 at 11:31 AM | msn.comModerna (NASDAQ:MRNA) Price Target Lowered to $78.00 at UBS GroupUBS Group dropped their price target on shares of Moderna from $96.00 to $78.00 and set a "buy" rating for the company in a research note on Wednesday.February 20 at 9:56 AM | marketbeat.comWill Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.February 20 at 3:22 AM | fool.comRoyal Bank of Canada Reaffirms "Sector Perform" Rating for Moderna (NASDAQ:MRNA)February 20 at 3:21 AM | americanbankingnews.comModerna (MRNA) Expected to Announce Earnings on ThursdayModerna (NASDAQ:MRNA) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=447621)February 20 at 2:48 AM | marketbeat.comBarclays Downgrades Moderna (NASDAQ:MRNA) to Equal WeightFebruary 20 at 2:31 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Stock Price Up 8.8% - Time to Buy?Moderna (NASDAQ:MRNA) Stock Price Up 8.8% - What's Next?February 19 at 10:14 PM | marketbeat.comStock Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA)Moderna, Inc. (NASDAQ:MRNA - Get Free Report) saw some unusual options trading activity on Tuesday. Traders purchased 179,268 call options on the company. This represents an increase of 83% compared to the typical volume of 97,935 call options.February 19 at 9:11 PM | marketbeat.comModerna's (MRNA) "Sector Perform" Rating Reiterated at Royal Bank of CanadaRoyal Bank of Canada reissued a "sector perform" rating and set a $40.00 price target on shares of Moderna in a research note on Tuesday.February 19 at 4:09 PM | marketbeat.comModerna price target lowered to $78 from $96 at UBSFebruary 19 at 11:33 AM | markets.businessinsider.comBiotech Stock Roundup: MRNA's Q4 Results, GILD's Update & Other NewsFebruary 19 at 11:33 AM | msn.comModerna: A Generational Opportunity for Investors in 2025Moderna had a weak quarter but reaffirmed guidance, expecting three new product approvals in 2025 and as many as ten more within three years.February 19 at 7:53 AM | marketbeat.comModerna (NASDAQ:MRNA) Stock Rating Lowered by BarclaysBarclays cut Moderna from an "overweight" rating to an "equal weight" rating and dropped their target price for the stock from $111.00 to $45.00 in a report on Tuesday.February 19 at 7:40 AM | marketbeat.comLouisiana State Employees Retirement System Has $757,000 Position in Moderna, Inc. (NASDAQ:MRNA)Louisiana State Employees Retirement System reduced its stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 62.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,200 shares of the company's stock aFebruary 19 at 3:36 AM | marketbeat.comModerna has limited upside: BarclaysFebruary 18 at 8:30 PM | msn.comAnalyst Confident In Moderna's Cancer Vaccine But Highlights Other ChallengesFebruary 18 at 8:30 PM | benzinga.comWhy Moderna (MRNA) Stock Is Up TodayFebruary 18 at 8:30 PM | msn.comModerna shares move higher as investors look beyond Q4 losses to pipeline potentialFebruary 18 at 2:57 PM | proactiveinvestors.comModerna price target raised to $39 from $38 at Morgan StanleyFebruary 17, 2025 | msn.comModerna reports decline in Q4 2024 revenueFebruary 17, 2025 | msn.comModerna, Inc. (NASDAQ:MRNA) Q4 2024 Earnings Call TranscriptFebruary 17, 2025 | insidermonkey.comBaillie Gifford & Co. Has $1.62 Billion Stake in Moderna, Inc. (NASDAQ:MRNA)Baillie Gifford & Co. trimmed its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 8.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 38,889,571 shares of the company's stock after selling 3,568February 17, 2025 | marketbeat.comIntrinsic Value Partners LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)Intrinsic Value Partners LLC cut its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 29.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 36,255 shares of the company's stock after selling 1February 16, 2025 | marketbeat.comBest Biotech Stocks To Keep An Eye On - February 14thModerna, Recursion Pharmaceuticals, Danaher, Thermo Fisher Scientific, and AbbVie are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are stocks of companies involved in the research, development, and commercialization of products based on bioloFebruary 15, 2025 | marketbeat.comModerna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.February 15, 2025 | yahoo.comModerna (NASDAQ:MRNA) Shares Gap Down - What's Next?Moderna (NASDAQ:MRNA) Shares Gap Down - Here's What HappenedFebruary 15, 2025 | marketbeat.comBanque Pictet & Cie SA Sells 22,425 Shares of Moderna, Inc. (NASDAQ:MRNA)Banque Pictet & Cie SA decreased its stake in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 0.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,132,974 shares of the company'sFebruary 15, 2025 | marketbeat.comCompagnie Lombard Odier SCmA Sells 8,018 Shares of Moderna, Inc. (NASDAQ:MRNA)Compagnie Lombard Odier SCmA lessened its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 6.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 120,286 shares of the company's stock afterFebruary 15, 2025 | marketbeat.comRep. Julie Johnson Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)Representative Julie Johnson (D-Texas) recently sold shares of Moderna, Inc. (NASDAQ:MRNA). In a filing disclosed on February 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Moderna stock on January 15th. The trade occurred in the Representative's "MERRILL LYNCHFebruary 15, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Purchased by Vontobel Holding Ltd.Vontobel Holding Ltd. boosted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 122.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 258,368 shares of the company's stock after acquiring an addFebruary 15, 2025 | marketbeat.comModerna swings to Q4 loss after nearly 66% drop in revenueFebruary 14, 2025 | msn.comModerna is counting on its product pipeline to resuscitate its ailing stockFebruary 14, 2025 | msn.comModerna Reports 2024 Loss, Eyes Future GrowthFebruary 14, 2025 | tipranks.comModerna (MRNA) Q4 2024 Earnings Call TranscriptFebruary 14, 2025 | msn.comModerna’s (NASDAQ:MRNA) Q4 Earnings Results: Revenue In Line With Expectations But Full-Year Sales Guidance Misses Expectations SignificantlyFebruary 14, 2025 | msn.comMovers: Roku, Moderna, GameStop, Palo AltoFebruary 14, 2025 | proactiveinvestors.comModerna, Inc.: Working Hard But Competition Is Working HarderFebruary 14, 2025 | seekingalpha.comModerna shares rise on quarterly revenue beat despite wider-than-expected lossFebruary 14, 2025 | proactiveinvestors.comModerna's Q4 Loss Wider Than ExpectedFebruary 14, 2025 | fool.comModerna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Guide DisappointsFebruary 14, 2025 | investopedia.comModerna's wider-than-expected loss and soft guidance weigh on battered stockFebruary 14, 2025 | marketwatch.comModerna beats on revenue but loses more than expected as it scales down manufacturingFebruary 14, 2025 | cnbc.comModerna posts bigger loss than expected as vaccine maker scales down manufacturingFebruary 14, 2025 | reuters.comBenchmarks Are Breaking Investment Management (And That's Our Opportunity)February 14, 2025 | seekingalpha.comModerna Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate AnalystsFebruary 14, 2025 | benzinga.comModerna earnings, retail sales data, FedSpeak: What to WatchFebruary 14, 2025 | finance.yahoo.comModerna Q4 Earnings Preview: COVID-19 Vaccine Sales, Bird Flu Vaccine Candidates On WatchFebruary 13, 2025 | benzinga.comModerna Q4 2024 Earnings Preview: Decline in revenue expectedFebruary 13, 2025 | msn.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.210.60▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼4724▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Viatris News Dr. Reddy's Laboratories News Vaxcyte News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
